In conclusion, ANGPTL2, which is upregulated in androgen-independent prostate cancer cells and human prostate cancer tissue after androgen ablation therapy, may be important in androgen-independent prostate cancer progression in an autocrine and/or paracrine manner via the integrin α5β1 receptor. The gene discussed is ANGPTL2; the disease is prostate cancer.